看这个

来源: fuz 于 2019-06-12 07:50:54 [] [博客] [旧帖] [给我悄悄话] 阅读数 : (1538 bytes)
本帖于 2019-06-12 08:04:48 时间, 由普通用户 fuz 编辑

临试 

https://clinicaltrials.gov/ct2/show/NCT03715114

https://ichgcp.net/clinical-trials-registry/NCT02293915

 

 

另几篇报道

https://www.biospace.com/article/releases/novel-drug-treatment-shows-improved-cognition-in-a-phase-3-clinical-trial-in-persons-with-mild-to-moderate-alzheimer-s-disease-in-china/ 

https://www.thepharmaletter.com/article/alzheimer-s-treatment-from-china-meets-phase-iii-goal

 

那个药

”GV-971 is a novel, marine-derived oligosaccharide, which has multi targeting mechanisms including inhibition of amyloid-β fibril formation, neuroinflammation, and recondition of dysbiosis of gut microbiota",

 

长期效果及副作用有待进一步评估

 

 

所有跟帖： 

• 谢谢夫子的信息 -越王- ♂ 给 越王 发送悄悄话 越王 的博客首页 (0 bytes) () 06/12/2019 postreply 08:07:07

请您先登陆，再发跟帖！